Nuvation Bio stockholders elect directors, ratify KPMG, approve say-on-pay at 2026 annual meeting

Nuvation Bio Inc.

Class A directors Robert B. Bazemore Jr. and Robert Mashal elected with 197.7M and 216.8M votes for, respectively.
Class B director Kim Blickenstaff elected with 1,000,000 votes for (no withhold).
Ratification of KPMG as independent auditor for FY 2026 approved with 290.3M votes for.
Advisory say-on-pay resolution passed with 230.1M votes for, 5.0M against, and 55.6M broker non-votes.

Key facts

Extracted from this filing and checked against the source text.

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

Nuvation Bio Inc. shareholders approved To approve, on an advisory basis, the compensation of the Company’s named executive officers as disclosed in the Proxy Statement. at the 2026-05-21 meeting.

Proposal: say on pay
Outcome: passed
Meeting: 2026-05-21

Exact text from the filing

Proposal No. 3 - To approve, on an advisory basis, the compensation of the Company’s named executive officers as disclosed in the Proxy Statement. The Company’s stockholders approved, on an advisory basis, the compensation of the Company’s named executive officers as disclosed in the Proxy Statement.

View on SEC.gov

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

Nuvation Bio Inc. shareholders approved Election of Directors at the 2026-05-21 meeting.

Proposal: director election
Outcome: passed
Meeting: 2026-05-21

Exact text from the filing

Proposal No. 1 - Election of Directors. The individuals listed below were elected at the Annual Meeting to serve as directors of the Company until the Company’s 2029 annual meeting of stockholders and until their successors are duly elected and qualified or until their earlier death, resignation or removal.

View on SEC.gov

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

Nuvation Bio Inc. shareholders approved Ratification of Independent Registered Public Accounting Firm at the 2026-05-21 meeting.

Proposal: auditor ratification
Outcome: passed
Meeting: 2026-05-21

Exact text from the filing

Proposal No. 2 - Ratification of Independent Registered Public Accounting Firm. The Company’s stockholders ratified the appointment of KPMG LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026.

View on SEC.gov

47 shareholder votes filed in the last 30 days. Browse all shareholder votes →

Nuvation Bio Inc. filing history →

Source: SEC EDGAR

accession 0001193125-26-241922

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.